2SEVENTY BIO, INC. - Annual Financials - Balance Sheet (SEC)

Updated on January 3, 2026.

Related Topics: SEC Topic List.

Data Source: SEC.

See details in table below.

You can see similar for other companies.

2SEVENTY BIO, INC. - Annual Balance Sheet (In Thousands of USD, Except Per Share Amounts)

Breakdown	2024-12-31	2023-12-31	2022-12-31
Cash and cash equivalents	71244	74958
Marketable securities	103510	142031
Prepaid expenses	4721	7365
Receivables and other current assets	7781	13411
Total current assets	187256	237765
Property, plant and equipment, net	33759	58150
Marketable securities	103510	142031
Intangible assets, net	5885	6594
Operating lease right-of-use assets	204391	219958
Restricted investments and other non-current assets	39352	38143
Total assets	479510	565426
Accounts payable	1055	6028
Accrued expenses and other current liabilities	22672	25688
Operating lease liability, current portion	16365	12660
Deferred revenue, current portion	0	15403
Total current liabilities	40092	59779
Deferred revenue, net of current portion	0	3918
Operating lease liability, net of current portion	227352	244013
Other non-current liabilities	1260	2416
Total liabilities	268704	310126
Commitments and contingencies (Note 9)	0	0
Preferred stock, $0.0001 par value; 10,000 shares authorized, 0 shares issued and outstanding at December 31, 2024 and December 31, 2023	0	0
Common stock, $0.0001 par value; 200,000 shares authorized, 51,589 and 50,632 shares issued and outstanding at December 31, 2024 and December 31, 2023 respectively	5	5
Additional paid-in capital	779176	766716
Accumulated other comprehensive income (loss)	89	-204
Accumulated deficit	-568464	-511217
Total stockholders equity	779176	-511217	606986
Total liabilities and stockholders equity	479510	565426
Preferred stock, par value per share (in dollars per share)	0.1	0.1
Preferred stock, shares authorized (in shares)	10000	10000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, shares authorized (in shares)	200000
Common stock, shares issued (in shares)	51589	50632
Common stock, shares outstanding (in shares)	51589	50632	37928